Boehringer Ingelheim Ditches Phase II Alzheimer's Program Post author:Sam Post published:February 8, 2018 Post category:BioPharma Another potential treatment for Alzheimer’s disease has been tossed into the rubbish bin. Source: BioSpace You Might Also Like Adapt Pharma Names President Of U.S. Operations April 11, 2016 ObsEva Fertility Drug Shows Some Promise in Late-Stage Trial February 25, 2018 It's Official: BiOptix Names New CEO April 10, 2017